Perioperative CA19‐9 value in pancreato‐biliary cancers has been recognized as a prognostic factor. Herein, we investigated survival differences and recurrence patterns after adjuvant chemoradiotherapy by perioperative CA19‐9 change in surgically… Click to show full abstract
Perioperative CA19‐9 value in pancreato‐biliary cancers has been recognized as a prognostic factor. Herein, we investigated survival differences and recurrence patterns after adjuvant chemoradiotherapy by perioperative CA19‐9 change in surgically resected extrahepatic cholangiocarcinoma.
               
Click one of the above tabs to view related content.